Evidence map›Paper›PMID 29316252›Full record

ArticleThoracic cancer2018

Manganese-12 acetate suppresses the migration, invasion, and epithelial-mesenchymal transition by inhibiting Wnt/β-catenin and PI3K/AKT signaling pathways in breast cancer cells.

Hongping Ju, Yongxia Li, Xiqian Xing, Xisong Miao, Yunping Feng, Yunhui Ren, Jing Qin, Dian Liu, Zihao Chen, Zhaoyu Yang

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Thoracic cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Micronutrient Status and Breast Cancer: A Narrative Review.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hongping JuSchool of Medicine, Kunming University, Kunming, China.
Yongxia LiThe Department of Respiratory Medicine, Second Ward, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Xiqian XingThe First Department of Respiratory Medicine, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, China.
Xisong MiaoSchool of Medicine, Kunming University, Kunming, China.
Yunping FengSchool of Medicine, Kunming University, Kunming, China.
Yunhui RenSchool of Medicine, Kunming University, Kunming, China.
Jing QinSchool of Medicine, Kunming University, Kunming, China.
Dian LiuSchool of Medicine, Kunming University, Kunming, China.
Zihao ChenThe Graduate School, Hebei Medical University, Shijiazhuang, China.
Zhaoyu YangSchool of Medicine, Kunming University, Kunming, China.ORCID 0000-0003-0526-6185
Kunming University · CNKunming Medical University · CNHebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is the leading cause of cancer-related death in the world, and it is of great value to reveal the molecular mechanisms of breast cancer progression and develop new therapeutic targets.

methodsTranswell assay is used to analyze the migration and invasion of breast cancer cells. Real-time PCR and western blotting assay are applied to detect the expression levels of epithelial-mesenchymal transition markers and the key members of Wnt/β-catenin and PI3K/AKT signaling pathways.

resultsManganese-12 acetate (Mn12Ac) significantly inhibited the migration and invasion of MCF7 and MDA-MB-231 breast cancer cells. Western blotting assay further showed that Mn12Ac significantly upregulated E-cadherin, and downregulated N-cadherin and vimentin. We further found that Mn12Ac reduced the mRNA expressions of epithelial-mesenchymal transition-associated transcription factors snail, slug, twist1, and ZEB1 using real-time PCR assay. Importantly, we further found that Mn12Ac significantly reduced the Wnt1 and β-catenin protein expressions, and suppressed the phosphorylation of PI3K and AKT in MCF7 and MDA-MB-231 breast cancer cells. Very interestingly, we also showed that Mn12Ac decreased the mRNA and protein expressions of programmed cell death ligand 1.

conclusionTaken together, our results suggested that Mn12Ac inhibited the migration, invasion, and epithelial-mesenchymal transition by regulating Wnt/β-catenin and PI3K/AKT signaling pathways in breast cancer.

Indexed as

Antineoplastic AgentsBreast NeoplasmsCell Line, TumorCell MovementEpithelial-Mesenchymal TransitionFemaleHumansManganese CompoundsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionWnt Signaling PathwayAntineoplastic AgentsManganese CompoundsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktBreast cancerinvasionmanganese-12 acetatemigration

Identifiers

PMID29316252
PMCPMC5832475
OpenAlexW2784186338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.